KYMERA THERAPEUTICS, INC.

Charts Kymera Therapeutics, Inc.

Equities

KYMR

US5015751044

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 20:00:00 13/03/2026 GMT			5-day change	1st Jan Change
79.03 ^USD	+1.97%		-5.34%	+1.57%

03-12	Kymera Therapeutics, Inc. Presents at Barclays 28th Annual Global Healthcare Conference, Mar-12-2026 09:30 AM
03-03	UBS Adjusts Price Target on Kymera Therapeutics to $128 From $90, Maintains Buy Rating	MT

Chart: Technical Analysis

ProRealTime Chart

Technical analysis trends

	Short Term	Mid-Term	Long Term
Trend	Neutral	Bullish	Bullish
Resistance	95.03	95.03	91.35
Spread/Res.	-16.84%	-16.84%	-13.49%
Spread/Supp.	+8.72%	+15.98%	+79.21%
Support	72.69	68.14	44.1

MarketScreener's Technical Analysis Ratings

Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes

Stock Market
Equities
KYMR Stock
Charts Kymera Therapeutics, Inc.

SPRING SALE - 40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!

BENEFIT NOW